Latest Blood disorders Stories
WASHINGTON, Dec. 20, 2012 /PRNewswire-USNewswire/ -- New research examining the role of race and ethnicity in an individual's decision to become a donor for hematopoietic cell transplantation (HCT) identifies several factors associated with varied participation rates in national donor registries across racial/ethnic groups. Results of this first-of-its-kind study are published online today in Blood, the Journal of the American Society of Hematology (ASH). Hematopoietic cell...
Kohl’s and the Milwaukee Journal Sentinel Team up with Aaron Rodgers to help fight childhood cancer and blood disorders Milwaukee, WI (PRWEB) December 03, 2012 Metro Milwaukee: Kohl’s Department Stores will donate 5 percent of every toy purchase made between Dec. 1 and Dec. 12, up to $100,000, to the MACC Fund (Midwest Athletes Against Childhood Cancer, Inc.) as part of the Aaron Rodgers 12 Days of Christmas program. Giving new meaning to the number on Rodgers’ jersey, the...
NEW YORK, Aug. 23, 2012 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (API), a private biopharmaceutical company that develops innovative targeted radio-immunotherapeutics, announced that the Company strengthened the management team with the hiring of Jack V. Talley as President and Chief Executive Officer and Enza Guagenti as Chief Financial Officer. Mr. Talley is a pharmaceutical industry veteran with more than thirty years of experience in marketing, drug development and...
A University of Rochester Medical Center study challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the patient is carefully examined and staged at diagnosis. The research underlines the fact that when cancer strikes, modern patients and their oncologists across the United States are taking many diverse treatment paths when there is scant data to support one method over another. This study...
WASHINGTON and BERLIN, Aug. 21, 2012 /PRNewswire-USNewswire/ -- Although parents should be the protectors of their children, they can also be their most severe abusers. This seems to be the case in the life of Ariana-Leilani King-Pfeiffer, a 9-year-old dual German/American Citizen whose father is denying her access to medication that would save her life. The child has been diagnosed with severe chronic neutropenia (SCN), a life-threatening disease affecting only one in one million...
CAMBRIDGE, Mass., Aug. 21, 2012 /PRNewswire/ -- Inspiration Biopharmaceuticals Inc. (Inspiration) today announced new license, development and commercialization agreements with its strategic partner, Ipsen (Euronext: IPN, ADR: IPSEY). The agreements restructure the existing partnership with Ipsen and provide Inspiration with additional funding to support development of its two investigational drugs in late-stage development for hemophilia, IB1001 and OBI-1. Under the terms of...
Discovery of the genetic basis of a high-risk subtype of leukemia shows some patients might benefit from existing targeted therapies, advancing the goal of curing all children with the most common childhood cancer Scientists have identified new genetic alterations underlying a high-risk subtype of the most common childhood cancer that could be effectively targeted with existing leukemia therapies. The study focused on a subtype of acute lymphoblastic leukemia (ALL) known as Philadelphia...
Scientists at Albert Einstein College of Medicine of Yeshiva University have made a discovery involving mice and humans that could mean that people with acute myeloid leukemia (AML), a rare and usually fatal cancer, are a step closer to new treatment options. "We have discovered that a gene called HLX is expressed at abnormally high levels in leukemia stem cells in a mouse model of AML," said Ulrich Steidl, M.D., Ph.D., assistant professor of cell biology and of medicine at Einstein and...
Discovery of the genetic basis of a high-risk subtype of leukemia shows some patients might benefit from existing targeted therapies, advancing the goal of curing all children with the most common childhood cancer MEMPHIS, Tenn., Aug. 13, 2012 /PRNewswire-USNewswire/ -- Scientists have identified new genetic alterations underlying a high-risk subtype of the most common childhood cancer that could be effectively targeted with existing leukemia therapies. The study focused on a...
SAN FRANCISCO, Aug. 9, 2012 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) is pleased to announce that America's Cup champions Ted Turner and Gary Jobson will attend the seventh annual Leukemia Cup Regatta weekend, October 20-21, 2012. Hosted by The San Francisco Yacht Club (SFYC) in Belvedere, CA, the Leukemia Cup Regatta supports LLS' mission to find a cure for leukemia, lymphoma, Hodgkin's disease and myeloma and improve the quality of life for patients and...
